Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLV308 Monotherapy in Early Stage Parkinson's Disease
2005-006033-32Phase 3Completed
- Sponsor
- Solvay
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease (PD) comparing SLV308 monotherapy with Placebo (2 arms). Started Mar 2006; status: completed.
02
Drugs
pardoprunox
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2005-006033-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006033-32.